Valuation: CVRx, Inc.

Market Cap 72.47M 63.6M 59.79M 54.66M 102M 6.94B 103M 718M 278M 3.54B 272M 266M 11.47B P/E 2026 *
-1.35x
P/E 2027 * -1.42x
Enterprise Value 82.97M 72.82M 68.45M 62.58M 117M 7.95B 118M 822M 319M 4.05B 312M 305M 13.14B EV / Sales 2026 *
1.41x
EV / Sales 2027 * 1.74x
Free-Float
80.18%
Yield 2026 *
-
Yield 2027 * -
1 day-1.47%
1 week-10.67%
Current month-9.46%
1 month-14.92%
3 months-48.01%
6 months-68.51%
Current year-62.25%
1 week 2.65
Extreme 2.65
3.07
1 month 2.65
Extreme 2.65
3.42
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 43 01/10/2020
Chief Operating Officer 57 11/08/2025
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/08/26 Buy

Chief Operating Officer

26,223 0.0988%
12/08/26 Sell

Chief Operating Officer

-1,309 0.0049%
01/06/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-1.10%-10.67%-64.08%-81.43% 72.47M
+0.13%+0.15%+25.90%+29.21% 12.58B
-0.65%+2.68%+16.88%+22.49% 6.76B
+0.27%-6.67% - - 5.78B
+1.92%+1.71%+32.54%+22.11% 5.49B
+0.88%+1.12%-18.42%+39.45% 5.09B
+0.79%+3.32%-28.47%-21.47% 3.97B
-1.11%-3.59%+25.55%-7.04% 1.89B
-0.85%-3.80%-15.51%+185.09% 1.67B
+1.49%-0.49%+49.27%-13.19% 1.56B
Average +0.19%-1.07%+2.63%+19.47% 4.49B
Weighted average by Cap. +0.33%-0.05%+12.94%+26.25%

Financials

2026 *2027 *
Net sales 58.85M 51.66M 48.56M 44.39M 82.96M 5.64B 83.57M 583M 226M 2.87B 221M 216M 9.32B 66.18M 58.09M 54.6M 49.92M 93.28M 6.34B 93.98M 656M 254M 3.23B 249M 243M 10.48B
Net income -53.45M -46.91M -44.1M -40.32M -75.34M -5.12B -75.9M -530M -205M -2.61B -201M -196M -8.46B -52.14M -45.76M -43.01M -39.33M -73.49M -4.99B -74.03M -517M -200M -2.55B -196M -191M -8.26B
Net Debt 10.5M 9.22M 8.67M 7.92M 14.8M 1.01B 14.91M 104M 40.35M 513M 39.44M 38.58M 1.66B 42.94M 37.69M 35.43M 32.39M 60.52M 4.11B 60.97M 426M 165M 2.1B 161M 158M 6.8B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
24/09/26 $2.690 -1.10% 16,575
23/09/26 $2.720 -5.88% 482,039
22/09/26 $2.890 -2.69% 666,182
21/09/26 $2.970 -2.30% 289,629
18/09/26 $3.040 +1.33% 810,573
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.720USD
Average target price
4.583USD
Spread / Average Target
+68.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock